Levonorgestrel and Ethinyl Estradiol

Phase 3Small molecule

Levonorgestrel and Ethinyl Estradiol is one of 35 small molecule programs targeting Contraception. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

ContraceptionActive, not recruiting

ContraceptionPhase 3

Active, not recruiting

Competition

Competitive Landscape

102 competitors in Contraception

#DrugCompanyPhaseTrials

Carbocaine

Pfizer

Phase 3

1 2

Depo-Provera

Eli Lilly

Phase 3

—3

Feldene

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Phase 3

2 4

Estradiol Valerate

Yasmin

1 6

Mirena

Bayer

Phase 3

4 7

Opill

LLaboratoire français de Fractionnement et de Biotechnologies

Phase 3

1 8

Norethindrone Acetate

WWatson Pharmaceuticals

Phase 3

2 9

Marvelon

Bayer

Phase 3

1 10

CDB 2914

HHRA Pharma

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Contraception2 trials

Study Evaluating Levonorgestrel and Ethinyl Estradiol in Oral Contraception

Completed· Pfizer logo

Pfizer·Phase 3·NCT00248963·600 enrolled

Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception

Unknown status·RRegenex Pharmaceutical, China·Phase 3·NCT02021097·1,008 enrolled

Ovulation1 trial

Evaluation of Pharmacodynamic Effects on Ovulation and Cycle Control

Completed·AAgile Therapeutics·Phase 2·NCT01250210·123 enrolled

Oral1 trial

Protease Inhibitors and Combined Oral Contraceptive Pharmacokinetics and Pharmacodynamics

Terminated·UUniversity of Southern California·Phase 4·NCT02531321·17 enrolled

Interaction1 trial

AZD6140 Oral Contraceptive Interaction Study

Completed· AstraZeneca logo

AstraZeneca·Phase 1·NCT00685906·24 enrolled

Hemostasis1 trial

Effects on Hemostasis, Lipids, Carbohydrate Metabolism, Adrenal & Thyroid Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG-EE (292004)(COMPLETED)(P05764)

Completed·OOrganon and Co·Phase 3·NCT00511355·121 enrolled

Sources

References

[1]
ClinicalTrials.gov — 6 trial records for Levonorgestrel and Ethinyl Estradiol. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Levonorgestrel and Ethinyl Estradiol compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Levonorgestrel and Ethinyl Estradiol. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Pfizer company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: Pfizer

Levonorgestrel and Ethinyl Estradiol

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Contraception2 trials

Ovulation1 trial

Oral1 trial

Interaction1 trial

Hemostasis1 trial

References

Drug Info

Quick Facts

Related News